Canaan Partners
http://www.canaan.com/homeCanaan Partners is a venture capital firm that invests in early stage technology and healthcare companies. Since its founding in 1987, Canaan has invested in more than 250 companies including DoubleClick and Match.com.
View Older Stories View More Recent Stories
-
Tari Gains Native Bitcoin Access & Cross-Chain Accessibility with Portal to Bitcoin Integration
-
Tari Gains Native Bitcoin Access & Cross-Chain Accessibility with Portal to Bitcoin Integration
-
Kepler Communications Appoints Dan Budlovsky As New Chief Financial Officer
-
Autobahn Therapeutics Completes Oversubscribed $100 Million Series C Financing to Advance Pipeline of Novel Therapeutics for Depression and Other CNS Disorders
-
Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
-
Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing
-
CatalYm Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab
-
Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London Intern
-
Nagish Raises $16 Million to Revolutionize Communication for Individuals with Hearing Loss Through AI
-
Form 13F-HR Canaan Partners XI LLC For: Jun 30
-
Form 13F-HR Canaan Partners IX LLC For: Jun 30
-
Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
-
ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program with Initial Focus on Inflammatory Gastrointestinal Disease Ulcerative Colitis
-
Only Four Months Out of Stealth, Aim Security Closes $18M Series A to Secure Generative AI Enterprise Adoption
-
Kepler Validates SDA-Compatible Optical Technology For Space Data Relay Constellation
-
Lev expands suite of CRE services with launch of AI-powered pipeline management tool
-
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Truveris Secures $15 Million in Series E Funding Through Canaan Partners and New Leaf Venture Partners
-
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
-
Pathios Therapeutics Raises $25M in First Close of Series B Financing to Advance First-in-Class Immunotherapy Approach into Clinic
-
Form 13F-HR Canaan Partners XI LLC For: Mar 31
-
Form 13F-HR Canaan Partners IX LLC For: Mar 31
-
Cancer biotech firm Alterome Therapeutics raises $132 million in Goldman Sachs-led round
-
Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
-
Software Supply Chain Security Leader Binarly Closes $10.5 Million Financing Led by Two Bear Capital
-
Lily AI Closes $20M Series B-1 Funding Round
-
Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development
-
IPSecure Closes Multiple Seven-Figure Seed II Round of Funding and Announces Formation of Key Advisory Board
-
Form 13F-HR Canaan Partners IX LLC For: Dec 31
-
Form 13F-HR Canaan Partners XI LLC For: Dec 31
-
Dusty Robotics Unveils Second Generation Robot and Comprehensive BIM-to-Field Automated Workflow
-
Reibus International Announces CEO Transition
-
Fireflies.ai Launches Mobile App, Bringing Its AI Notetaker to In-Person Meetings
-
JOOR Raises $25M to Accelerate Growth and Innovation; Expand in Payments and New Categories
-
Form 13F-HR Canaan Partners X LLC For: Sep 30
-
Form 13F-HR Canaan Partners XI LLC For: Sep 30
-
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
-
Pathios Therapeutics Awarded Innovate UK Grant to Evaluate First-in-Class Immunotherapy Approach in Models of Malignant Brain Cancer
-
Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
-
Lev Announces the Launch of Lev AI
-
ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers
-
Atmosfy Announces $12 Million in Seed Funding as it Surpasses One Million Local Businesses on the Platform
-
Form 13F-HR Canaan Partners XI LLC For: Jun 30
-
Form 13F-HR Canaan Partners X LLC For: Jun 30
-
World View Names New Chief Financial Officer and Appoints New Member to Its Board of Directors
-
CircleUp Acquired by Brightflow AI
-
Brightflow AI Acquires CircleUp to Deepen Customer Insights and Help Small Businesses Grow
-
OncoResponse Awarded $13 Million in Funding from CPRIT and Raises $14 Million in Added Funds from Investors to Advance Cancer Immunotherapy
-
Lev Announces the Launch of Lev Match
-
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO

